5,465
Views
18
CrossRef citations to date
0
Altmetric
Coronaviruses

Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein

ORCID Icon, , , ORCID Icon, , , , , , , , , , , , , , , , , , & ORCID Icon show all
Pages 351-367 | Received 04 Nov 2021, Accepted 28 Dec 2021, Published online: 24 Jan 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shafiul Haque, Darin Mansor Mathkor, Mustfa Faisal Alkhanani, Farkad Bantun, Aiman M. Momenah, Hani Faidah, Naif A. Jalal & Vijay Kumar. (2023) Comprehensive deep mutational scanning reveals the pH induced stability and binding differences between SARS-CoV-2 spike RBD and human ACE2. Journal of Biomolecular Structure and Dynamics 41:24, pages 15207-15218.
Read now

Articles from other publishers (17)

Sijie YangYuanling YuFanchong JianAyijiang YisimayiWeiliang SongJingyi LiuPeng WangYanli XuJing WangXiao NiuLingling YuYao WangFei ShaoRonghua JinYouchun Wang & Yunlong Cao. (2024) Antigenicity assessment of SARS-CoV-2 saltation variant BA.2.87.1. Emerging Microbes & Infections.
Crossref
Yamin Chen, Jialu Zha, Shiqi Xu, Jiang Shao, Xiaoshan Liu, Dianfan Li & Xiaoming Zhang. (2024) Structure-Based Optimization of One Neutralizing Antibody against SARS-CoV-2 Variants Bearing the L452R Mutation. Viruses 16:4, pages 566.
Crossref
Daming Zhou, Piyada Supasa, Chang Liu, Aiste Dijokaite-Guraliuc, Helen M. E. Duyvesteyn, Muneeswaran Selvaraj, Alexander J. Mentzer, Raksha Das, Wanwisa Dejnirattisai, Nigel Temperton, Paul Klenerman, Susanna J. Dunachie, Elizabeth E. Fry, Juthathip Mongkolsapaya, Jingshan Ren, David I. Stuart & Gavin R. Screaton. (2024) The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86. Nature Communications 15:1.
Crossref
Anders Frische, Karen Angeliki Krogfelt, Anders Fomsgaard & Ria Lassaunière. (2024) Antigen-Heterologous Vaccination Regimen Triggers Alternate Antibody Targeting in SARS-CoV-2-DNA-Vaccinated Mice. Vaccines 12:3, pages 218.
Crossref
Wenhao Liu, Zehong Huang, Jin Xiao, Yangtao Wu, Ningshao Xia & Quan Yuan. (2024) Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness. Viruses 16:2, pages 184.
Crossref
Cong Xu, Wenyu Han & Yao Cong. (2023) Cryo-EM and cryo-ET of the spike, virion, and antibody neutralization of SARS-CoV-2 and VOCs. Current Opinion in Structural Biology 82, pages 102664.
Crossref
Lihong Liu, Ryan G. Casner, Yicheng Guo, Qian Wang, Sho Iketani, Jasper Fuk-Woo. Chan, Jian Yu, Bernadeta Dadonaite, Manoj S. Nair, Hiroshi Mohri, Eswar R. Reddem, Shuofeng Yuan, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Kwok-Yung Yuen, Zizhang Sheng, Yaoxing Huang, Jesse D. Bloom, Lawrence Shapiro & David D. Ho. (2023) Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking. Immunity 56:10, pages 2442-2455.e8.
Crossref
Anders Frische, Vithiagaran Gunalan, Karen Angeliki Krogfelt, Anders Fomsgaard & Ria Lassaunière. (2023) A Candidate DNA Vaccine Encoding the Native SARS-CoV-2 Spike Protein Induces Anti-Subdomain 1 Antibodies. Vaccines 11:9, pages 1451.
Crossref
Shailendra Mani, Anupamjeet Kaur, Kamini Jakhar, Geetika Kumari, Sudipta Sonar, Amit Kumar, Sudesna Das, Santosh Kumar, Vijay Kumar, Rakesh Kundu, Anil Kumar Pandey, Umesh Prasad Singh & Tanmay Majumdar. (2023) Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infections. International Journal of Biological Macromolecules 245, pages 125444.
Crossref
Daming Zhou, Jingshan Ren, Elizabeth E Fry & David I Stuart. (2023) Broadly neutralizing antibodies against COVID-19. Current Opinion in Virology 61, pages 101332.
Crossref
Enya Qing & Tom Gallagher. (2023) Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages. mBio.
Crossref
James A. Williams, Marco BiancucciLaura Lessen, Sai Tian, Ankita BalsarafLynn ChenChelsy Chesterman, Giulietta Maruggi, Sarah VandepaerYing HuangCorey P. Mallett, Ann-Muriel Steff, Matthew James Bottomley, Enrico Malito, Newton Wahome & Wayne D. Harshbarger. (2023) Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity. Science Advances 9:23.
Crossref
Baoxu Lin, Linlin Cheng, Jin Zhang, Mei Yang, Yixiao Zhang, Jianhua Liu & Xiaosong Qin. (2023) Immunology of SARS-CoV-2 infection and vaccination. Clinica Chimica Acta 545, pages 117390.
Crossref
Zhiyang Ling, Chunyan Yi, Xiaoyu Sun, Zhuo Yang & Bing Sun. (2022) Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodies. Science China Life Sciences 66:4, pages 658-678.
Crossref
Memoona Aslam, M. Saqib Nawaz, Philippe Fournier-Viger & Wenjin Li. (2023) Comparative Analysis and Classification of SARS-CoV-2 Spike Protein Structures in PDB. COVID 3:4, pages 452-471.
Crossref
Siqi He, Jiali Wang, Hanyi Chen, Zhaohui Qian, Keping Hu, Bingjie Shi & Jianxun Wang. (2023) A Competitive Panning Method Reveals an Anti-SARS-CoV-2 Nanobody Specific for an RBD-ACE2 Binding Site. Vaccines 11:2, pages 371.
Crossref
Qin Hong, Wenyu Han, Jiawei Li, Shiqi Xu, Yifan Wang, Cong Xu, Zuyang Li, Yanxing Wang, Chao Zhang, Zhong Huang & Yao Cong. (2022) Molecular basis of receptor binding and antibody neutralization of Omicron. Nature 604:7906, pages 546-552.
Crossref